JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A2614 Bortezomib (PS-341)
58 Citation

Target: Proteasome

Summary: proteasome inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
A4304 Rosiglitazone
7 Citation

Summary: Potent PPARγ agonist

insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
A4325 PF-2545920

Target: Phosphodiesterases (PDEs)

Summary: PDE10A inhibitor,potent and selective

insoluble in H2O; ≥19.35 mg/mL
A4393 Paclitaxel (Taxol)
29 Citation

Target: Microtubules/Tubulins

Summary: microtubule depolymerization inhibitor

≥85.6 mg/mL
A1930 M50054

Summary: Associate with caspase-3 inhibition
A1932 (-)-Huperzine A

Target: NMDA Receptors|AChE

Summary: NMDA receptor antagonist/AChE inhibitor

insoluble in H2O; ≥12.12 mg/mL
A3123 4'-Demethylepipodophyllotoxin

Summary: Anti-cancer drug

≥83.33 mg/mL
A3238 BEZ235 Tosylate
1 Citation

Summary: MTOR/P13K inhibitor

Soluble in DMSO
A3240 BIBX 1382

Summary: EGFR inhibitor,potent and selective

Soluble in DMSO
A3241 Bilobalide

Summary: Neuroprotective agent

insoluble in H2O; ≥16.32 mg/mL